Entecavir Rollover Study in Chronic Hepatitis B

Phase 2, open-label, single-arm trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Primary endpoint: To provide open-label entecavir to subjects who have completed previous blinded entecavir trials in Japan and are assessed by the investigator as likely to benefit from additional anti-hepatitis B… at 24 weeks. Started Dec 2003; status: completed.